VCYT
Veracyte Inc
39.80$
-1.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +29.6% | +31.5% | +10.6% | +27.9% | +30.8% | -2.4% | +86.8% | +35.1% | +21.8% | +23.5% | +16.0% | |
| – | +29.5% | +18.4% | +10.7% | +17.3% | +10.4% | +13.5% | +79.5% | +36.5% | +11.1% | +30.7% | +6.4% | |
| – | +29.8% | +41.5% | +10.4% | +34.7% | +42.3% | -9.3% | +90.9% | +34.3% | +27.3% | +20.1% | +20.8% | |
| – | +30.5% | +19.8% | -9.4% | +6.8% | +0.2% | +15.8% | +73.5% | +36.1% | +41.1% | +20.9% | +2.2% | |
| – | +19.8% | +5.3% | -2.9% | +3.8% | +21.1% | +26.5% | +175.9% | -24.5% | +106.0% | +13.1% | -37.9% | |
| – | +21.5% | +11.3% | +2.7% | +15.5% | +21.9% | +12.6% | +103.8% | +4.0% | +41.5% | -15.6% | +1.4% | |
| – | – | – | – | – | – | – | – | – | – | – | +359.4% | |
| – | -13.9% | +629.4% | +79.2% | -60.3% | -65.5% | -66.2% | +5.2% | -17.8% | -92.4% | -86.7% | -50.0% | |
| – | – | – | – | – | – | – | – | – | – | – | +164.9% | |
| – | – | +471.2% | +83.1% | -77.9% | +224.3% | -75.8% | -748.8% | – | -1,760.2% | – | +15.1% | |
| – | – | – | – | – | – | – | – | – | – | – | +174.9% | |
| – | – | – | – | – | – | – | – | – | – | – | +82.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.